Treatonic hemorrhoid treatment
- Product NDC
- 85569-008
- 11-digit product format
- 855690008
- Labeler code
- 85569
- Product ID
- 85569-008_58db951c-2398-4a7c-e063-6394a90a02c6
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- 5% lidocaine
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- 100 KARMA INC
- Application
- M015
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2025-10-31
- Substance
- LIDOCAINE; PHENYLEPHRINE HYDROCHLORIDE
- Active strength
- 2.5; .125 g/50g; g/50g
- Pharmacologic classes
- Adrenergic alpha1-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], alpha-1 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 85569-008 | D | Discontinued by firm | 2026-10-12 | ||
| excluded package | package | 85569-008 | 85569-008-01 | D | Discontinued by firm | 2026-10-12 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | 85569-008 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… | ||
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 85569-008 | 85569-008-01 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Treatonic hemorrhoid treatment
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LIDOCAINE | 2.5 g/50g |
| PHENYLEPHRINE HYDROCHLORIDE | .125 g/50g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 98PI200987 | Internal UNII lookup |
| 04JA59TNSJ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1314136 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 41442fa7-c511-07ca-e063-6294a90a3992 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85569-008-01 | Treatonic hemorrhoid treatment | 50 g in 1 CARTON | CREAM | 50 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | 4eb3c9ac-268a-5246-e054-00144ff88e88 | 2025-06-09 | Warnings | M015 |
| Bunnies Bum Anorectal Numbing | LIDOCAINE | FloCal Distributors LLC | 3712e151-d171-1c5d-e063-6294a90a36c0 | 2025-06-08 | Warnings | M015 |
| RECOVERY Numbing | LIDOCAINE HCL | Renu Laboratories, LLC | e4e05cae-56a6-b2b3-e053-2a95a90a104b | 2025-06-06 | Warnings | M015 |
| Hemorrohoid Master Cream | LIDOCAINE, PHENYLEPHRINE HCL | Ebanel Laboratories, Inc. | 36eccc74-107e-3914-e063-6294a90a1856 | 2025-06-06 | Warnings | M015 |
| Numb 520 | LIDOCAINE | Ebanel Laboratories, Inc | 36c9988b-9e61-ebbf-e063-6394a90a4114 | 2025-06-04 | Warnings | M015 |
| Hemorrhoid Master | LIDOCAINE, PHENYLEPHRINE HCL | Clinical Resolution Laboratory, Inc. | 36caf20d-116a-f86a-e063-6294a90a7b62 | 2025-06-04 | Warnings | M015 |
| Quick Numb | LIDOCAINE | Clinical Resolution Laboratory, Inc. | 351b95a6-e038-d9aa-e063-6294a90a4172 | 2025-05-29 | Warnings | M015 |
| Dibucaine Topical Anesthetic 1% Hemorrhoidal | DIBUCAINE | Rugby Laboratories Inc. | f23c8cd1-98f9-41cd-84d4-cf01c2ede29a | 2025-05-29 | Warnings | M015 |
| The Femme Fix Hemorrhoid Treatment | LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE | POPPY COLLECTIVE LLC | 5217b5d9-b835-4428-a6b3-e6b255630742 | 2025-05-27 | Warnings | M015 |
| MAXOCAINE Topical Anesthetic Anorectal | LIDOCAINE | PRIME COMMERCE, LLC | 26e8c867-8cb8-4a25-91b1-da45a1edd09a | 2025-05-27 | Warnings | M015 |
| Numb25 | LIDOCAINE | Ebanel Laboratories, Inc. | 35107403-55ae-c627-e063-6394a90a0b5c | 2025-05-27 | Warnings | M015 |
| Numb 520 | LIDOCAINE | Ebanel Laboratories, Inc | 350e4d5e-dac7-ae4e-e063-6394a90a76b4 | 2025-05-27 | Warnings | M015 |
| Numb25 | LIDOCAINE 5% | Ebanel Laboratories, Inc | 350fd302-8fd5-5288-e063-6294a90aa382 | 2025-05-27 | Warnings | M015 |
| Numb 520 | LIDOCAINE | Ebanel Laboratories, Inc | 35095bed-0e91-c44a-e063-6294a90add6e | 2025-05-27 | Warnings | M015 |
| Numb520 | LIDOCAINE | Clinical Resolution Laboratory, Inc. | a0411950-c6ee-4427-acb6-3cef58b0e93e | 2025-05-15 | Warnings | M015 |
| Numb25 | LIDOCAINE | Clinical Resolution Laboratory, Inc. | cfcb839d-47b4-4925-bb30-97b64d20d2b3 | 2025-05-15 | Warnings | M015 |
| Numb520 | LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE | Clinical Resolution Laboratory, Inc. | 65d3b614-361d-4fb9-9583-a95be754bc82 | 2025-05-15 | Warnings | M015 |
| Chamosyn | BARRIER CREAM | Links Medical Products | f9dfb2d7-4684-4525-994e-1e0ff90413d9 | 2025-05-08 | Warnings | M015 |
| LANOZEM HEMORRHOIDAL | MENTHOL, PETROLATUM | Sod-e Biotech Ltd | 34901e83-8f24-8460-e063-6394a90a2744 | 2025-05-07 | Warnings | M015 |
| PREPARATION H | PHENYLEPHRINE HYDROCHLORIDE | Haleon US Holdings LLC | 96d2e0e7-2de0-4660-9ffd-9edb2ad224d8 | 2025-04-18 | Warnings | M015 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1314136 | lidocaine 5 % / phenylephrine HCl 0.25 % Rectal Cream | PSN | 41442fa7-c511-07ca-e063-6294a90a3992 | 1 |
| 1314136 | lidocaine 50 MG/ML / phenylephrine hydrochloride 2.5 MG/ML Rectal Cream | SCD | 41442fa7-c511-07ca-e063-6294a90a3992 | 1 |
| 1314136 | lidocaine 5 % / phenylephrine hydrochloride 0.25 % Rectal Cream | SY | 41442fa7-c511-07ca-e063-6294a90a3992 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 85569-008-01 | 85569000801 | 50 g in 1 CARTON (85569-008-01) | 50 g | 2025-10-31 | No | No | Current |